基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
无可用的信号评分。
Discover the full record of transactions filed by Hamilton John F, 董事. Officer active across 1 company, notably Aridis Pharmaceuticals, Inc.. Aggregated, 2 filings have been recorded. Breakdown: 1 buy · 0 sell. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
John F. Hamilton is a Board Member at Aridis Pharmaceuticals, Inc. He brings his expertise in corporate governance and strategy to the management team. Hamilton is involved in key decisions regarding product development and the strategic direction of the company. His experience in the pharmaceutical sector is a valuable asset for Aridis.